Applied DNA Announces Third Quarter Fiscal 2021

Go back to Applied DNA Announces Third Quarter Fiscal 2021

Applied DNA Sciences (APDN) Misses Q3 EPS by 24c

August 12, 2021 4:30 PM EDT

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.46), $0.24 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $3.13 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

... More